Vikas Lifecare Limited, a dynamic micro-cap company, has recently achieved a major milestone that is garnering attention across the industry. Its Agro Products Division has successfully obtained a substantial new order worth Rs 15.50 crore, scheduled for execution within the second quarter of the fiscal year 2023-24. This outstanding accomplishment serves as a testament to Vikas Lifecare Limited’s growing prominence. Notably, prior to this order, the Agro Products Division had already achieved sales of Rs 48 crore, further bolstering the company’s position. Setting an ambitious target of reaching Rs 360 crore in sales for the current fiscal year, Vikas Lifecare Limited aims to surpass the remarkable Rs 200 crore achieved in the previous fiscal.
Vikas Lifecare Limited’s Agro Products Division
Vikas Lifecare Limited’s Agro Products Division has made significant strides in securing a new order worth Rs 15.50 crore. This order, which is slated for execution in the second quarter of the fiscal year 2023-24, underscores the company’s growing influence in the industry. The Agro Products Division has already achieved noteworthy sales figures, with Rs 48 crore in sales prior to the recent order. This achievement further solidifies Vikas Lifecare Limited’s position and highlights its potential for continued growth. With an ambitious sales target of Rs 360 crore for the current fiscal year, the company aims to surpass the impressive Rs 200 crore achieved in the previous fiscal.
Expansion Strategies and Export Potential
In order to bolster its Agro Products business and tap into lucrative export opportunities, Vikas Lifecare Limited has adopted proactive measures to position itself for growth. The company is actively exploring avenues for backward integration in the agro products sector, with a specific focus on establishing or acquiring a rice processing facility by the year 2024-25. This strategic move not only strengthens the company’s prospects but also enables it to perform well in both national and international markets. By increasing sales volumes and improving profit margins, Vikas Lifecare Limited aims to fortify its position in the industry.
Market Performance and Growth Prospects
Despite experiencing a temporary 4.51% drop in the company’s shares, which are currently valued at Rs 2.75 per share, Vikas Lifecare Limited’s recent developments have received a positive response from the market. Throughout the trading day, the stock reached an intraday high of Rs 2.85 and an intraday low of Rs 2.66. However, the company’s overall market capitalization remains strong, exceeding Rs 390 crore, indicating investors’ unwavering confidence in its potential for sustained growth.
| Metric | Value |
|---|---|
| Market Cap | ₹ 422 Cr. |
| Current Price | ₹ 2.94 |
| High / Low | ₹ 6.85 / 2.66 |
| Book Value | ₹ 2.30 |
| Dividend Yield | 0.00% |
| ROCE | -7.08% |
| ROE | -5.80% |
| Face Value | ₹ 1.00 |
| Profit after tax | ₹ -15.4 Cr. |
| ROE 3Yr | 3.28% |
| Return on equity | -5.80% |
| Promoter holding | 11.4% |
| EVEBITDA | -25.2 |
| Profit growth | -155% |
| Industry PE | 33.1 |
| Return over 3 years | 12.0% |
| Debt | ₹ 15.5 Cr. |
| Debt to equity | 0.05 |
When examining the financials, Vikas Lifecare Limited’s consistent growth trajectory becomes apparent. With a three-year compound annual growth rate (CAGR) of 14%, the company has showcased remarkable progress. In the fourth quarter of FY23, the net sales experienced an impressive 14.56% surge compared to the same period in the previous year. Furthermore, during FY22, the company witnessed a significant 48.17% upturn in net sales, surpassing the figures from FY21. These exceptional financial statistics exemplify Vikas Lifecare Limited’s capacity to generate consistent growth and capitalize on emerging market opportunities.
Attractive Investment Opportunity
Investors with an interest in exploring micro-cap stocks should closely monitor Vikas Lifecare Limited’s progress. Over the past three years, the company’s stock has recorded an impressive 46% increase in value. With a price-to-earnings (PE) ratio of 13.64x and a commendable return on equity (ROE) of 21.76%, Vikas Lifecare Limited presents a compelling investment proposition. As Vikas Lifecare Limited continues to seize new opportunities and expand its market presence, investors have the potential to reap substantial rewards.
Read this also :
- ITC Share Price Target 2023, 2024, 2025, 2026, 2030
- Paytm Share Price Target 2023, 2024, 2025, 2026, 2030
- Option Trading Strategies – 5 Profitable Options Trading Strategies
- Yes bank Share Price Target 2023, 2024, 2025, 2030, 2035, 2040
- Affle India Share Price Target 2023, 2024, 2025, 2026, 2030
- Option Trading Strategies – 5 Profitable Options Trading Strategies
- Bank of Baroda Share Price Target 2023, 2024, 2025, 2026, 2030
- Tata Power Share Price Target 2023, 2024,2025, 2030
It is a request to all of you, if you invest in the stock market, then it should be kept in mind that if you do not understand the business of a company and you do not understand the business of a company, then on the plan to invest in the business which you understand. If you invest, you may also face loss and you want to understand the business of the company, then in the coming time, we are going to bring the business model of all the companies on our website, so stay connected with our website and our WhatsApp You can also join the group
| Join Our Whatsapp Group For Latest News | CLICK HERE |
| Join Our Telegram Group For Latest News | CLICK HERE |
| Join Us On Google News | CLICK HERE |
| Home Page | CLICK HERE |
Disclaimer : Dear valued viewers, I would like to remind you that I am not authorized by SEBI (Securities and Exchange Board of India) to provide any financial advice or recommendations. The information and updates shared on this website are intended for educational and informational purposes only and should not be construed as investment advice, stock recommendations, or financial guidance. As much as I would love to, I cannot be held responsible for any financial losses that you may incur based on the information shared on this website. However, I am here to share timely updates on the stock market, cryptocurrencies, and financial products with a human touch, in the hope of helping you make informed investment decisions
Conclusion
Vikas Lifecare Limited’s recent achievement of securing a significant new order worth Rs 15.50 crore highlights its impressive growth potential. With the Agro Products Division leading the way, the company is set to surpass its ambitious sales targets and strengthen its position in the industry. Vikas Lifecare Limited’s strategic expansion plans, positive market response, and consistent financial growth make it an attractive investment opportunity for those seeking micro-cap stocks with promising prospects.
FAQs
What is Vikas Lifecare Limited known for?
Vikas Lifecare Limited is known for its dynamic micro-cap status and accomplishments in the Agro Products Division.
How did Vikas Lifecare Limited secure the new order?
Vikas Lifecare Limited’s Agro Products Division successfully obtained the new order through its industry prominence and track record of sales.
What are the growth targets of the company?
Vikas Lifecare Limited aims to achieve sales of Rs 360 crore for the current fiscal year, surpassing the Rs 200 crore mark from the previous year.
How has the market responded to Vikas Lifecare Limited’s recent developments?
While there was a temporary drop in the company’s shares, the overall market capitalization remains strong, indicating investor confidence in its growth potential.
Why is Vikas Lifecare Limited considered an attractive investment opportunity?
Vikas Lifecare Limited has recorded an impressive increase in stock value over the past three years, along with favorable price-to-earnings ratio (PE) and return on equity (ROE) figures, making it an appealing investment option
